JERSEY CITY, N.J. (AP) - JERSEY CITY, N.J. (AP) - Scynexis Inc. (SCYX) on Wednesday reported a loss of $2.8 million in its third quarter. On a per-share basis, the Jersey City, New Jersey-based company said it had a loss of 6 cents. The pharmaceutical company posted revenue of $660,000 in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SCYX at https://www.zacks.com/ap/SCYX
Scynexis is a New Jersey-based biotechnology company that researches, develops, and commercializes novel anti-infective therapies for the treatment of fungal infections.